Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-071367
Filing Date
2025-05-14
Accepted
2025-05-14 16:05:35
Documents
63
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q drrx-20250331.htm   iXBRL 10-Q 1405501
2 EX-31.1 drrx-ex31_1.htm EX-31.1 12640
3 EX-31.2 drrx-ex31_2.htm EX-31.2 12077
4 EX-32.1 drrx-ex32_1.htm EX-32.1 6366
5 EX-32.2 drrx-ex32_2.htm EX-32.2 6807
  Complete submission text file 0000950170-25-071367.txt   6951035

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT drrx-20250331.xsd EX-101.SCH 1004208
65 EXTRACTED XBRL INSTANCE DOCUMENT drrx-20250331_htm.xml XML 1306280
Mailing Address 10240 BUBB ROAD CUPERTINO CA 95014
Business Address 10240 BUBB ROAD CUPERTINO CA 95014 4087771417
DURECT CORP (Filer) CIK: 0001082038 (see all company filings)

EIN.: 943297098 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-31615 | Film No.: 25945331
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)